Medical News
Risk of Incident Type 2 Diabetes in Patients with Psoriatic...
Int. J. Rheum. Dis.
Our study indicates a 38% increase in the risk of type 2 diabetes among patients with PsA, with an incidence rate...
30 Jun 2022
Higher Risk of Knee Arthroplasty During Ten-year Follow-up i...
BMC Musculoskelet. Disord.
In a sample of middle-aged individuals with complaints in one or both knees, the 10-year relative hazard for...
24 Jun 2022
Longitudinal Trajectories of Fatigue in Early RA: The Role o...
Annals of Rheumatol
Although fatigue evolves dynamically over time in early RA, most patients do not achieve sustained fatigue...
23 Jun 2022
2022 ACR/AAHKS Guideline for the Perioperative Management of...
J Arthroplasty
This updated guideline includes recently introduced immunosuppressive medications to help decision-making by...
20 Jun 2022
eCMEs
Key Trials
Efficacy of Teriparatide on Prior Use to Lumbar Fusion Surgery in Patients with Poor Bone Health
The present study assessed the two-year complication rates for patients who have poor bone health, with or without teriparatide pre-treatment before...
Risk MACE or Cancers with Tofacitinib verses TNF Inhibitor in RA Patients
This study assessed the risk of cardiovascular disease and cancer with tofacitinib and TNF inhibitor in patients with rheumatoid arthritis. The...
Effectiveness of ZOL as a First-line Therapeutic Strategy After Percutaneous Kyphoplasty
The present study evaluated the efficacy of zoledronic acid (ZOL) administration against previously treated recompression vertebral fractures (RVF)...
Cardioprotective Effect of Oral Bisphosphonates
The present study determined the risk of incident cardiovascular disease associated with oral BP (oBP) use in oBP users and non-users. The findings...
Patient Education
Osteoporosis:Video
The public awareness video gives an overview of osteoporosis and its management in patient friendly visuals and language.
General Awareness on Hydroxychloroquine Tablets
This educational input provides patient counselling information as per prescribing information on Hydroxychloroquine tablets regarding its therapeuti...
General Awareness on Methotrexate Tablets
This educational input provides patient counselling information as per prescribing information on methotrexate tablets regarding its therapeutic usag...
General Awareness on Tofacitinib Tablets
This educational input provides patient counselling information as per prescribing information on Tofacitinib tablets regarding its therapeutic usage...
Our Publications
Zotide (Teriparatide ) Monograph
The currently available pharmacological treatments for osteoporosis are predominantly anti-resorptive. These inhibit osteoclast-mediated bone loss...
Hyruan (Hyaluronic Acid) Monograph
Osteoarthritis (OA) is the most common form of arthritis and is a major cause of debilitation for affected individuals. One of the nonsurgical...
Calcinase (calcitonin) – Monograph
This monograph covers various aspects of osteoporosis management and pharmacology, clinical efficacy & safety of calcitonin in treatment of...
Imutrex (methotrexate) – Getting to the Heart of Rheumatoid Arthritis Abstracts Booklet
This publication features efficacy & safety studies of methotrexate in management of rheumatoid arthritis.
Slide Library
Intraarticular Hyaluronic acid for Osteoarthirits
The presentation includes description of synovial hyaluronic acid, its viscoelastic property, mechanism of action and different types available in...
Osteoarthritis
This presentation shows the structure of bone joint majorly affected in osteoarthritis, its pathophysiology, risk factors, signs and symptoms and...
Recommendations for Up & Downscaling of Methotrexate Dose in Rheumatoid Arthritis
Methotrexate (MTX) is the first-line treatment for early and clearly defined rheumatoid arthritis (RA). This presentation summarizes the...
Musculoskeletal Manifestations of Ulcerative Colitis
This slide set covers the common musculoskeletal manifestations of inflammatory bowel diseases (IBD) and its management. The spectrum of these...
.jpg)
Poll
Which of the following bisphosphonate is preferred as first line treatment of osteoporosis-
Alendronate
Risedronate
Ibandronate
Zoledronic acid
Total votes: 7